Sources and methodology

Introduction

This document provides an overview of the data sources used for the metrics within the ABPI impact mapping tool, as well as the methodologies applied to process the data for each metric.

 

Economy

Manufacturing sites:

Data source(s)

Data details

Bioscience and health technology sector statistics (BaHTSS) dataset.

BaHTSS 2021 to 2022 site-level data provides detailed information about sites within the bioscience and health technology sector.

Methodology:

  1. Identify biopharmaceutical manufacturing sites. Filtered for biopharmaceutical companies and then identified manufacturing organisations from the business activity codes.

  2. The site postcode information available in the dataset was used for geographical mapping purposes at a local and regional level.

Source URL:

https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021-to-2022

Note: Sites identified via the tool will include a combination of biopharmaceutical companies manufacturing medicines and vaccines, and capture some companies within the service and supply sector which provide key input materials, or part of the medicines manufacturing process. See methodology:

 

Jobs

Data source(s)

Data details

ONS

The dataset provides Census 2021 estimates that classify usual residents aged 16 years and over in employment the week before the census in England and Wales by industry. Estimates are as at Census Day, 21 March 2021.

Methodology:

  1. The Fraser of Allander Institute report (Feb 2023) [1] was used to identify SIC07 codes, and their respective percentages related to the UK biopharmaceutical industry.

    1. SIC21: Manufacture of basic pharmaceutical products and pharmaceutical preparations (100%)

    2. SIC72: Scientific research and development (12%)

  2. It is assumed that the composition of SIC07 codes representing the biopharmaceutical industry remains the same across all regions within the UK.

  3. The ONS data source includes data on employment sector for England and Wales at constituency level. Using post-2019 Westminster constituency data.

  4. Biopharmaceutical industry employment in Scotland was identified using the Fraser of Allander Institute – The economic contribution of the Pharmaceuticals Sector in Scotland (Feb 2023) [1].

    1. The value of full-time equivalent (FTE) employment in the wider pharmaceutical sector was used. The composition of SIC07 codes defining the wider pharmaceutical sector in ‘The economic contribution of the Pharmaceuticals Sector in Scotland’ (Feb 2023) [1] is as follows:

      1. SIC21: Manufacture of basic pharmaceutical products and pharmaceutical preparations (100%)

      2. SIC46: Wholesale trade, except for motor vehicles and motorcycles (0.51%)

      3. SIC70: Activities of head offices; management consultancy activities (0.02%)

      4. SIC72: Scientific research and development (12%)

    2. The contribution of FTE from SIC46 and SIC70 is not specified in ‘The economic contribution of the Pharmaceuticals Sector in Scotland’ (Feb 2023) [1]. Therefore, SIC46 and SIC70 are included in the final value of biopharmaceutical industry employment in Scotland.
  1. Northern Ireland biopharmaceutical industry employment was identified using the Fraser of Allander Institute - The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland (May 2022) [2].

    1. The value of full-time equivalent (FTE) employment in the wider pharmaceutical sector was used. The composition of SIC07 codes defining the wider pharmaceutical sector in ‘The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland’ (May 2022) [2] is as follows:

      1. SIC21: Manufacturing of basic pharmaceuticals products and pharmaceutical preparations

      2. SIC 46.46: Wholesale of pharmaceutical goods

      3. SIC72: Scientific research and development
  1. Biopharmaceutical industry employment at the constituency level for Scotland and Northern Ireland was calculated by applying population weighting.

Source URLs:

https://www.ons.gov.uk/datasets/TS060/editions/2021/versions/1/filter-outputs/c7ca84c2-6dee-468c-8fcb-41f8055eb1f7#get-data

 

Percentage of pharmaceutical jobs

Data source(s)

Data details

ONS

The dataset provides Census 2021 estimates that classify usual residents aged 16 years and over in employment the week before the census in England and Wales by industry. Estimates are as at Census Day, 21 March 2021.

Scottish Government

The data source provides a report detailing Census 2021 estimates of employment of Scottish residents ages 16 years and over [4].

NISRA

This dataset provides Census 2021 estimates that classify usual residents aged 16 years and over in employment the week before the census in Northern Ireland by industry, and by sex. The estimates are as at census day, 21 March 2021.

Methodology:

  1. The numerator is the number of biopharmaceutical industry jobs for a given geography, please refer to the Jobs section above.

  2. The denominator is the total observed jobs for the same geography.

    1. Total observed jobs for England and Wales were identified from the ONS data source; this data is available at constituency level. Using post-2019 Westminster constituency data.

    2. Total observed jobs for Scotland were obtained from GOV Scotland; this figure was provided at a regional level [4].

    3. Total observed jobs for Northern Ireland were obtained from the NISRA. The identified value represents the regional figure for total observed jobs for Northern.

Source URLs:

https://www.ons.gov.uk/datasets/TS060/editions/2021/versions/1/filter-outputs/c7ca84c2-6dee-468c-8fcb-41f8055eb1f7#get-data https://www.nisra.gov.uk/system/files/statistics/census-2021-ms-h06.xlsx

 

Value added through employment - gross value added (GVA)

Data source(s)

Data details

ONS

ONS regional gross value added (balanced) by industry (2021) - ITL1 & UK, current price estimates, pounds million table.

Methodology:

  1. The available data for this metric was at a regional level.

  2. Using ONS regional GVA by industry data (2021), the total GVA for the biopharmaceutical industry was calculated by summing SIC21 (100%) and SIC72 (12%).

  3. The average gross value added per industry job was calculated at a national level. The national average GVA per industry job was used to compute the value added through employment at a constituency level. 

Source URL:

https://www.ons.gov.uk/economy/grossvalueaddedgva/datasets/nominalandrealregionalgrossvalueaddedbalancedbyindustry

 

Partnerships

NHS partnerships

Data source(s)

Data details

ABPI Disclosure UK data

Healthcare organisation 2022 disclosure data

Methodology:

  1. Identification of NHS Partnerships. Partnerships with NHS organisations were identified from 2022 Disclosure UK data. This dataset served as the primary source for identifying the collaborations between NHS organisations and the life science industry.

  2. Geographical Mapping. The postcode of the partner NHS organisation was used for mapping the partnership.

 

 

Industry contributions to the NHS

Data source(s)

Data details

ABPI Disclosure UK data

Healthcare organisation 2022 disclosure data

Methodology:

  1. Total contribution calculation. The total contribution to the NHS is determined by summing two components, the collaborative working amount, and donations and grants given to healthcare organisations (HCO).

  2. The postcode of the HCO that receives the contribution is used for geographical mapping.

Research

Research sites

Data source(s)

Data details

Bioscience and health technology sector statistics (BaHTSS) dataset.

BaHTSS 2021 to 2022 site-level data provides detailed information about sites within the bioscience and health technology sector.

Methodology:

  1. Filtering for R&D sites. The data was filtered to specifically focus on research and development (R&D) sites.

  2. Mapping using site postcode. The site postcode information available in the dataset was used for geographical mapping purposes at a local and regional level.

Source URL:

https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021-to-2022

 

 

Clinical trial enrolment

Data source(s)

Data details

The data for this metric was obtained from the ABPI (Association of the British Pharmaceutical Industry).

The data was from 2022/23 and at LCRN level for England and regional level for Scotland, Northern Ireland, and Wales.

Methodology:

  1. Mapping of Local Clinical Research Networks (LCRN). A mapping was created to link the local clinical research networks to their respective UK regions.

  2. The clinical trial recruitment data was aggregated at the UK region level.

 

References:

[1] Fraser of Allander Institute The economic contribution of the Pharmaceuticals Sector in Scotland (2023). Available at: https://fraserofallander.org/wp-content/uploads/2023/02/The-Economic-Contribution-of-the-Pharmaceutical-Sector-to-Scotlands-Economy-2023.pdf

[2] Fraser of Allander Institute The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland (2022). Available at: https://fraserofallander.org/wp-content/uploads/2022/05/FAI-The-economic-contribution-of-the-pharmaceutical-sector-in-Northern-Ireland-FOR-SHARING.pdf

[3] GOV.UK. (n.d.). Bioscience and health technology sector statistics 2021. [online] Available at: https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021.

[4] The Scottish Government (2022) Scotland’s labour market: People, places, and regions – protected characteristics. statistics from the annual Population Survey 2021, Scottish Government. Available at: https://www.gov.scot/publications/scotlands-labour-market-people-places-regions-protected-characteristics-statistics-annual-population-survey-2021/  (Accessed: 05 January 2024).

Last modified: 19 June 2024

Last reviewed: 19 June 2024